Survey of current molecular and cellular mechanisms driving metabolic dysfunction-associated steatotic liver disease and its progression to hepatocellular carcinoma.
Key Takeaways
- G polymorphism confers an increased risk of non-alcoholic fatty liver disease associated hepatocellular carcinoma
- MASLD is now the most prevalent chronic liver disease worldwide and a rising indication for liver transplantation
- MASH is a significant risk factor for fibrosis